Faculty Opinions recommendation of Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study.

Author(s):  
Klaus Bielefeldt
Sign in / Sign up

Export Citation Format

Share Document